{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:13:55Z","timestamp":1782958435812,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"PHC Holdings Corporation."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-80686-7","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T12:45:32Z","timestamp":1733229932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Urinary presepsin is a novel biomarker capable of directly assessing monocyte\/macrophage infiltration in kidney diseases"],"prefix":"10.1038","volume":"14","author":[{"given":"Shunsuke","family":"Niwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikao","family":"Onogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Sunohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Owaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Kawazoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Koshi-Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritoshi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Kosugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"80686_CR1","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/ki.2011.198","volume":"80","author":"RG Fassett","year":"2011","unstructured":"Fassett, R. G. et al. Biomarkers in chronic kidney disease: a review. Kidney Int. 80, 806\u2013821 (2011).","journal-title":"Kidney Int."},{"key":"80686_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/ki.2008.17","volume":"73","author":"CR Parikh","year":"2008","unstructured":"Parikh, C. R. & Garg, A. X. Acute kidney injury: better biomarkers and beyond. Kidney Int. 73, 801\u2013803 (2008).","journal-title":"Kidney Int."},{"key":"80686_CR3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1053\/j.ajkd.2021.03.026","volume":"78","author":"JH Ix","year":"2021","unstructured":"Ix, J. H. & Shlipak, M. G. The promise of tubule biomarkers in kidney disease: a review. Am. J. Kidney Dis. 78, 719\u2013727 (2021).","journal-title":"Am. J. Kidney Dis."},{"key":"80686_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/j.1365-2362.2007.01885.x","volume":"37","author":"P Stratta","year":"2007","unstructured":"Stratta, P. et al. Risk management of renal biopsy: 1387 cases over 30 years in a single centre. Eur. J. Clin. Investig. 37, 954\u2013963 (2007).","journal-title":"Eur. J. Clin. Investig."},{"key":"80686_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1053\/j.ajkd.2012.02.330","volume":"60","author":"KM Corapi","year":"2012","unstructured":"Corapi, K. M., Chen, J. L. T., Balk, E. M. & Gordon, C. E. Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am. J. Kidney Dis. 60, 62\u201373 (2012).","journal-title":"Am. J. Kidney Dis."},{"key":"80686_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/ckj\/sfv012","volume":"8","author":"N Prasad","year":"2015","unstructured":"Prasad, N. et al. Real-time ultrasound-guided percutaneous renal biopsy with needle guide by nephrologists decreases post-biopsy complications. Clin. Kidney J. 8, 151\u2013156 (2015).","journal-title":"Clin. Kidney J."},{"key":"80686_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.935700","volume":"13","author":"YJ Huang","year":"2022","unstructured":"Huang, Y. J., Lin, C. H., Yang, H. Y., Luo, S. F. & Kuo, C. F. Urine Soluble CD163 Is a Promising Biomarker for the Diagnosis and Evaluation of Lupus Nephritis. Front Immunol. 13, 935700 (2022).","journal-title":"Front Immunol."},{"key":"80686_CR8","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1681\/ASN.2021030382","volume":"11","author":"SM Moran","year":"2021","unstructured":"Moran, S. M. et al. The Clinical Application of Urine Soluble CD163 in ANCA-Associated Vasculitis. J Am Soc Nephrol. 11, 2920\u20132932 (2021).","journal-title":"J Am Soc Nephrol."},{"key":"80686_CR9","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/ndt\/gfaa097","volume":"36","author":"Y Yokoe","year":"2021","unstructured":"Yokoe, Y. et al. Clinical impact of urinary CD11b and CD163 on the renal outcomes of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Nephrol Dial Transplant. 36, 1452\u20131463 (2021).","journal-title":"Nephrol Dial Transplant."},{"key":"80686_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jiac.2015.04.011","volume":"21","author":"Y Arai","year":"2015","unstructured":"Arai, Y. et al. Phagocytosis by human monocytes is required for the secretion of presepsin. J. Infect. Chemother. 21, 564\u2013569 (2015).","journal-title":"J. Infect. Chemother."},{"key":"80686_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s10156-005-0400-4","volume":"11","author":"Y Yaegashi","year":"2005","unstructured":"Yaegashi, Y. et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J. Infect. Chemother. 11, 234\u2013238 (2005).","journal-title":"J. Infect. Chemother."},{"key":"80686_CR12","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/s10156-011-0254-x","volume":"17","author":"T Shozushima","year":"2011","unstructured":"Shozushima, T. et al. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J. Infect. Chemother. 17, 764\u2013769 (2011).","journal-title":"J. Infect. Chemother."},{"key":"80686_CR13","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s10156-012-0435-2","volume":"18","author":"S Endo","year":"2012","unstructured":"Endo, S. et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J. Infect. Chemother. 18, 891\u2013897 (2012).","journal-title":"J. Infect. Chemother."},{"key":"80686_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jiac.2013.07.005","volume":"20","author":"S Endo","year":"2014","unstructured":"Endo, S. et al. Presepsin as a powerful monitoring tool for the prognosis and treatment of sepsis: a multicenter prospective study. J. Infect. Chemother 20, 30\u201334 (2014).","journal-title":"J. Infect. Chemother"},{"key":"80686_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13613-017-0316-z","volume":"7","author":"CC Wu","year":"2017","unstructured":"Wu, C. C. et al. Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: a systematic review and meta-analysis. Ann. Intensive Care 7, 91 (2017).","journal-title":"Ann. Intensive Care"},{"key":"80686_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2253-14-88","volume":"14","author":"Y Nakamura","year":"2014","unstructured":"Nakamura, Y. et al. Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury. BMC Anesthesiol. 14, 88 (2014).","journal-title":"BMC Anesthesiol."},{"key":"80686_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cca.2018.09.013","volume":"490","author":"Y Nakamura","year":"2019","unstructured":"Nakamura, Y. et al. Comparison of accuracy of presepsin and procalcitonin concentrations in diagnosing sepsis in patients with and without acute kidney injury. Clin. Chim. Acta. 490, 200\u2013206 (2019).","journal-title":"Clin. Chim. Acta."},{"key":"80686_CR18","doi-asserted-by":"publisher","unstructured":"Kim, S. Y., Hong, D. Y., Lee, K. R., Paik, J. H. & Jung, H. M. Plasma presepsin level predicts acute kidney injury in patients with sepsis in the emergency department. Medicine (Baltimore) 101, e29919; https:\/\/doi.org\/10.1097\/MD.0000000000029919 (2022)","DOI":"10.1097\/MD.0000000000029919"},{"key":"80686_CR19","doi-asserted-by":"publisher","unstructured":"Nagata, T. et al. Clinical impact of kidney function on presepsin levels. PLoS One 10, e0129159; https:\/\/doi.org\/10.1371\/journal.pone.0129159 (2015).","DOI":"10.1371\/journal.pone.0129159"},{"key":"80686_CR20","doi-asserted-by":"publisher","unstructured":"Miyoshi, M. et al. Clinical evaluation of presepsin considering renal function. PLoS One 14: e0215791; https:\/\/doi.org\/10.1371\/journal.pone.0215791 (2019).","DOI":"10.1371\/journal.pone.0215791"},{"key":"80686_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2019.09.012","volume":"500","author":"S Kobayashi","year":"2020","unstructured":"Kobayashi, S., Amano, H., Terawaki, H., Kawaguchi, Y. & Yokoo, T. Prediction of presepsin concentrations through commensurate decline in kidney function in the elderly. Clin. Chim. Acta 500, 1\u20139 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"80686_CR22","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1515\/cclm-2022-0027","volume":"60","author":"V Botondi","year":"2022","unstructured":"Botondi, V. et al. Perinatal asphyxia partly affects presepsin urine levels in non-infected term infants. Clin. Chem. Lab. Med. 60, 793\u2013799 (2022).","journal-title":"Clin. Chem. Lab. Med."},{"key":"80686_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12879-023-08353-2","volume":"23","author":"R Yamashita","year":"2023","unstructured":"Yamashita, R., Izumi, Y., Nakada, K. & Hiramoto, J. Utility of urinary presepsin in the diagnosis of pyelonephritis: a cross-sectional study. BMC. Infect. Dis. 23, 365 (2023).","journal-title":"BMC. Infect. Dis."},{"key":"80686_CR24","doi-asserted-by":"publisher","unstructured":"Mysore, V. et al. Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2. J. Exp. Med. 219, e20210562; https:\/\/doi.org\/10.1084\/jem.20210562 (2022).","DOI":"10.1084\/jem.20210562"},{"key":"80686_CR25","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s42003-022-03712-2","volume":"5","author":"Y Shimamura","year":"2022","unstructured":"Shimamura, Y. et al. Mesenchymal stem cells exert renoprotection via extracellular vesicle-mediated modulation of M2 macrophages and spleen-kidney network. Commun. Biol. 5, 753 (2022).","journal-title":"Commun. Biol."},{"key":"80686_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ab.2007.12.030","volume":"375","author":"T Kurihara","year":"2008","unstructured":"Kurihara, T. et al. Evaluation of cardiac assays on a benchtop chemiluminescent enzyme immunoassay analyzer. PATHFAST. Anal. Biochem. 375, 144\u2013146 (2008).","journal-title":"PATHFAST. Anal. Biochem."},{"key":"80686_CR27","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1016\/j.cca.2011.07.024","volume":"412","author":"Y Okamura","year":"2011","unstructured":"Okamura, Y. & Yokoi, H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin. Chim. Acta 412, 2157\u20132161 (2011).","journal-title":"Clin. Chim. Acta"},{"key":"80686_CR28","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1128\/JCM.03052-14","volume":"53","author":"D Stubljar","year":"2015","unstructured":"Stubljar, D. et al. Diagnostic accuracy of presepsin (sCD14-ST) for prediction of bacterial infection in cerebrospinal fluid samples from children with suspected bacterial meningitis or ventriculitis. J. Clin. Microbiol. 53, 1239\u20131244 (2015).","journal-title":"J. Clin. Microbiol."},{"key":"80686_CR29","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.2147\/IDR.S325635","volume":"14","author":"G Zheng","year":"2021","unstructured":"Zheng, G., Zhang, C., Zhang, G. & Shao, C. Evaluation of the diagnostic and prognostic value of CSF presepsin levels in patients with postneurosurgical ventriculitis\/meningitis. Infect. Drug Resist. 14, 2901\u20132909 (2021).","journal-title":"Infect. Drug Resist."},{"key":"80686_CR30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12890-018-0740-3","volume":"18","author":"N Watanabe","year":"2018","unstructured":"Watanabe, N. et al. The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions. BMC Pulm. Med. 18, 176 (2018).","journal-title":"BMC Pulm. Med."},{"key":"80686_CR31","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ijid.2020.10.030","volume":"102","author":"T Imagama","year":"2021","unstructured":"Imagama, T. et al. Synovial fluid presepsin as a novel biomarker for the rapid differential diagnosis of native joint septic arthritis from crystal arthritis. Int. J. Infect. Dis. 102, 472\u2013477 (2021).","journal-title":"Int. J. Infect. Dis."},{"key":"80686_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.cca.2013.09.019","volume":"427","author":"C Chenevier-Gobeaux","year":"2014","unstructured":"Chenevier-Gobeaux, C., Trabattoni, E., Roelens, M., Borderie, D. & Claessens, Y. E. Presepsin (sCD14-ST) in emergency department: the need for adapted threshold values?. Clin. Chim. Acta 427, 34\u201336 (2014).","journal-title":"Clin. Chim. Acta"},{"key":"80686_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.14712\/18059694.2018.35","volume":"48","author":"S Sk\u00e1lov\u00e1","year":"2005","unstructured":"Sk\u00e1lov\u00e1, S. The diagnostic role of urinary N-acetyl-beta-D-glucosaminidase (NAG) activity in the detection of renal tubular impairment. Acta Medica (Hradec Kralove) 48, 75\u201380 (2005).","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"80686_CR34","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.2215\/CJN.02370310","volume":"5","author":"Y Wu","year":"2010","unstructured":"Wu, Y. et al. Pathological significance of a panel of urinary biomarkers in patients with drug-induced tubulointerstitial nephritis. Clin. J. Am. Soc. Nephrol. 5, 1954\u20131959 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"80686_CR35","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1093\/ndt\/gfw214","volume":"31","author":"N Endo","year":"2016","unstructured":"Endo, N. et al. Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis. Nephrol. Dial. Transplant. 31, 2023\u20132033 (2016).","journal-title":"Nephrol. Dial. Transplant."},{"key":"80686_CR36","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1681\/ASN.2019121285","volume":"31","author":"JM Mejia-Vilet","year":"2020","unstructured":"Mejia-Vilet, J. M. et al. Urinary soluble CD163: a novel noninvasive biomarker of activity for lupus nephritis. J. Am. Soc. Nephrol. 31, 1335\u20131347 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"80686_CR37","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.2215\/CJN.07210520","volume":"15","author":"JP Aendekerk","year":"2020","unstructured":"Aendekerk, J. P. et al. Urinary soluble CD163 and disease activity in biopsy-proven ANCA-associated glomerulonephritis. Clin. J. Am. Soc. Nephrol. 15, 1740\u20131748 (2020).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"80686_CR38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210562","volume":"219","author":"V Mysore","year":"2022","unstructured":"Mysore, V. et al. Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2. J Exp Med. 219, e20210562 (2022).","journal-title":"J Exp Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80686-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80686-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80686-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T13:07:10Z","timestamp":1733231230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80686-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["80686"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-80686-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was supported by PHC Holdings Corporation. PATHFAST was rented, presepsin measurement kits were provided free of charge, and we also received a grant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30088"}}